- Exchange: Stockholm
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Whsle Drug Dist
Snapshot for Meda AB (MEDAA)
| Open: | 68.900 | Day's Range: | 68.600 - 69.600 | Volume: | 988,241 | Bid: | 69.400 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 68.550 | 52wk Range: | 51.850 - 79.750 | 1-Yr Rtn: | +5.42% | Ask: | 69.500 |
Key Statistics for MEDAA
| Current P/E Ratio (ttm) | 12.9907 |
|---|---|
| Estimated P/E (12/2012) | 6.8406 |
| Earnings Per Share (SEK) (ttm) | 5.3500 |
| Est. EPS (SEK) (12/2012) | 10.1600 |
| Est. PEG Ratio | 0.7534 |
| Market Cap (M SEK) | 21,005.89 |
| Shares Outstanding (M) | 302.24 |
| Enterprise Value (M SEK) (ttm) | 36,578.89 |
| Enterprise Value/EBITDA (ttm) | 7.81 |
| Price/Book (mrq) | 1.3831 |
| Price/Sale (ttm) | 1.5808 |
| Dividend Indicated Gross Yield | 3.2374 |
| Next Earnings Announcement | 08/03/2012 |
More MEDAA Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for MEDAA
- Operating
- Investing
- Financing (M/SEK)
Company Profile & Key Executives for MEDAA
Meda AB is a specialty pharmaceutical company. The Company imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. Meda's products are sold in the Nordic countries and in the Baltic states on behalf of foreign manufacturers. The Company markets to wholesale dealers and hospitals.
| Bert-Ake ErikssonChairman | Anders LonnerPresident/CEO |
| Henrik StenqvistChief Financial Officer | Joerg-Thomas DierksChief Operating Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page